Strides Pharma Inc.
Strides Pharma Inc. lists 28 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 42543-493 | Amantadine Hydrochloride Capsule | Amantadine Hydrochloride 100 mg/1 | Rx |
| 42543-497 | Amantadine Hydrochloride Tablet | Amantadine Hydrochloride 100 mg/1 | Rx |
| 42543-741 | Buspirone Hydrochloride Tablet | Buspirone Hydrochloride 5 mg/1 | Rx |
| 42543-742 | Buspirone Hydrochloride Tablet | Buspirone Hydrochloride 10 mg/1 | Rx |
| 42543-743 | Buspirone Hydrochloride Tablet | Buspirone Hydrochloride 15 mg/1 | Rx |
| 42543-744 | Buspirone Hydrochloride Tablet | Buspirone Hydrochloride 30 mg/1 | Rx |
| 42543-787 | Buspirone Hydrochloride Tablet | Buspirone Hydrochloride 7.5 mg/1 | Rx |
| 59556-894 | cetirizine hydrochloride Capsule, Liquid Filled | Cetirizine Hydrochloride 10 mg/1 | OTC |
| 42543-719 | Emtricitabine and Tenofovir Disoproxil Fumarate Tablet | Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 | Rx |
| 42543-970 | Hydrocortisone Tablet | Hydrocortisone 5 mg/1 | Rx |
| 42543-971 | Hydrocortisone Tablet | Hydrocortisone 10 mg/1 | Rx |
| 42543-972 | Hydrocortisone Tablet | Hydrocortisone 20 mg/1 | Rx |
| 59556-764 | Ibuprofen Capsule, Liquid Filled | Ibuprofen 200 mg/1 | OTC |
| 59556-895 | Ibuprofen Capsule, Liquid Filled | Ibuprofen 200 mg/1 | OTC |
| 59556-855 | Ibuprofen Immediate Release Tablet, Coated | Ibuprofen 200 mg/1 | OTC |
| 59556-856 | Ibuprofen Immediate Release Tablet, Coated | Ibuprofen 200 mg/1 | OTC |
| 59556-857 | IBUPROFEN Immediate Release Tablet, Coated | Ibuprofen 200 mg/1 | OTC |
| 59556-858 | IBUPROFEN Immediate Release Tablet, Coated | Ibuprofen 200 mg/1 | OTC |
| 59556-282 | Levonorgestrel Tablet, 1.5 mg Tablet | Levonorgestrel 1.5 mg/1 | OTC |
| 59556-959 | Loperamide Hydrochloride Capsule, Liquid Filled | Loperamide Hydrochloride 2 mg/1 | OTC |
| 59556-301 | Loratadine Tablet | Loratadine 5 mg/1 | OTC |
| 59556-917 | Loratadine Tablet, Orally Disintegrating | Loratadine 10 mg/1 | OTC |
| 42543-988 | Mycophenolate mofetil Capsule | Mycophenolate Mofetil 250 mg/1 | Rx |
| 42543-989 | Mycophenolate mofetil Tablet, Film Coated | Mycophenolate Mofetil 500 mg/1 | Rx |
| 59556-286 | Optionelle Tablet | Levonorgestrel 1.5 mg/1 | OTC |
| 42543-406 | Potassium Citrate Extended Release Tablet | Potassium Citrate 5 meq/1 | Rx |
| 42543-408 | Potassium Citrate Extended Release Tablet | Potassium Citrate 15 meq/1 | Rx |
| 42543-407 | Potassium Citrate Extended Release Tablet | Potassium Citrate 10 meq/1 | Rx |
Recalls by Strides Pharma Inc.
- D-0260-2024 Jan 31, 2024 · Class II
Failed Dissolution Specifications - D-0895-2023 Jul 12, 2023 · Class II
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet. - D-1330-2022 Aug 17, 2022 · Class II
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets - D-0974-2022 Jun 8, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0973-2022 Jun 8, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0972-2022 Jun 8, 2022 · Class II
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits - D-0006-2022 Oct 20, 2021 · Class II
Failed Dissolution Specifications - D-0180-2021 Jan 6, 2021 · Class III
Failed Moisture Limits